![Ronald Aldridge](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Ronald Aldridge worked as a Senior Director of Investor Relations at PAREXEL International Corp.
from 2016 to 2017.
He also worked as the Head of Investor Relations at The Nassau Cos.
of New York, Inc. and as an Investor Relations Contact at Constellation Pharmaceuticals, Inc.
Tidigare kända positioner av Ronald Aldridge
| Företag | Position | Slut |
|---|---|---|
| PAREXEL INTERNATIONAL CORPORATION | Investor Relations Kontakt | 2017-10-01 |
| CONSTELLATION PHARMACEUTICALS, INC. | Investor Relations Kontakt | - |
| THE PHOENIX COMPANIES, INC. | Offentlig kommunikationskontakt | - |
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
16
Första gradens relationer
3
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 3 |
|---|---|
PAREXEL International Corp.
 PAREXEL International Corp. BiotechnologyHealth Technology Operates as a clinical research organization which provides insights-driven clinical and consulting solutions | Health Technology |
The Nassau Cos. of New York, Inc.
 The Nassau Cos. of New York, Inc. Multi-Line InsuranceFinance Operates as a holding company with interest in providing annuities, life and health insurance services | Finance |
Constellation Pharmaceuticals, Inc.
 Constellation Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops novel drugs targeting regulators of epigenetic function | Health Technology |
